Quickstart Highlights
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor. Its key advantage is high specificity for GH release without triggering ACTH or cortisol elevation, making it one of the safer GH secretagogues with minimal off-target hormonal effects. This educational protocol presents a once-daily subcutaneous approach (optionally 2–3 times daily for advanced users) with nominal volume calculations that require verification against the actual device.
- Reconstitute: Add 1.0 mL BAC water per labelled 10 mg vial; calculations assume a final volume of 1.0 mL and nominal concentration of 10 mg/mL.
- Typical daily range: 100–300 mcg per injection once daily before bed (gradual titration recommended); optionally 2–3 times daily (fasted morning and/or pre-training doses) for advanced users. Cycle 8–12 weeks on, then 4 weeks off.
- Scale conversion: At 10 mg/mL, 1 U-100 unit = 0.01 mL = 100 mcg. Confirm actual device markings; this arithmetic does not establish measurement accuracy.
- Storage: Lyophilized: 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within ~4 weeks.
Dosing & Reconstitution Guide
Standard / Gradual Approach (1 mL = 10 mg/mL)
| Week | Daily Dose (mcg) | Calculated volume | U-100 scale value (1 mL capacity) | V1 nominal setting (units) |
|---|---|---|---|---|
| Weeks 1–2 | 100 mcg | 0.01 mL | 1 units | 1 unit |
| Weeks 3–4 | 150 mcg | 0.015 mL | 1.5 units (requires matching fractional-unit markings) | Not representable in whole units |
| Weeks 5–8 | 200 mcg | 0.02 mL | 2 units | 2 units |
| Weeks 9–12 | 250 mcg | 0.025 mL | 2.5 units (requires matching fractional-unit markings) | Not representable in whole units |
Calculation basis: The table uses the labelled 10 mg amount and assumes a final solution volume of 1.0 mL (10 mg/mL). BAC volume does not change the amount of peptide. These are nominal calculations, not validation of preparation, compatibility or treatment.
Frequency: Inject once daily subcutaneously, ideally 30–60 minutes before bedtime on an empty stomach to synergize with natural nocturnal GH secretion. Advanced users may optionally dose 2–3 times daily (adding fasted morning and/or pre-training doses) at 100–300 mcg per injection. Run 8–12 weeks on, then 4 weeks off. For doses ≤10 units (≤0.10 mL), consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
- Draw 1.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake vigorously).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–12 week protocol with gradual titration, calculated at one injection per day. Advanced users adding fasted morning and/or pre-training doses (2–3 injections daily) multiply the syringe and swab counts and use vials faster, so scale these totals accordingly.
- Peptide Vials (Ipamorelin, 10 mg each):
- 8 weeks ≈ 2 vials
- 12 weeks ≈ 2–3 vials
- Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- Bacteriostatic Water (30 mL bottles): Use 1.0 mL per vial. These volume-only totals use the listed vial counts; wastage and opened-bottle discard limits may require more.
- 8 weeks (2 vials): 2 mL → 1 × 30 mL bottle(s), minimum by volume
- 12 weeks (2–3 vials): 2–3 mL → 1 × 30 mL bottle(s), minimum by volume
- Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.
- Goal: Stimulate endogenous growth hormone release to support anabolic processes related to muscle growth, fat metabolism, and tissue repair.
- Schedule: Daily subcutaneous injections before bed for 8–12 weeks (optionally 2–3 times daily for advanced users), followed by 4 weeks off to resensitize receptors.
- Dose Range: 100–300 mcg per injection with gradual titration; 200 mcg is a common middle-of-the-road dose.
- Reconstitution: 1.0 mL BAC per labelled 10 mg vial; nominal 10 mg/mL under the stated final-volume assumption.
- Storage: Lyophilized refrigerated or frozen; reconstituted refrigerated; use within ~4 weeks.
Dosing Protocol
Suggested daily titration approach.
- Start: 100 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
- Target: 200–250 mcg daily by Weeks 5–12.
- Frequency: Once per day (subcutaneous), ideally 30–60 minutes before bedtime; optionally 2–3 times daily (fasted morning and/or pre-training doses) for advanced users.
- Cycle Length: 8–12 weeks on, then 4 weeks off.
- Timing: Evening bedtime dosing preferred; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at 2–8 °C (35.6–46.4 °F) for short-term or −20 °C (−4 °F) for long-term storage in dry, dark conditions.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~4 weeks with bacteriostatic water. For longer storage, freeze aliquots at −20 °C (−4 °F) and avoid repeated freeze–thaw cycles.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each injection; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; wait a few seconds before withdrawing the needle.
- Document daily dose and site rotation to maintain consistency.
- Ipamorelin has a short half-life (~1.5–2.5 hours); consistent daily timing maximizes effects.
How This Works
Ipamorelin binds to the growth hormone secretagogue receptor (GHSR-1a) and stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner. Unlike earlier growth hormone releasing peptides, ipamorelin is highly selective and does not significantly stimulate ACTH, cortisol, or prolactin release at effective doses. After subcutaneous injection, GH levels peak within approximately 40 minutes and return to baseline by 2–3 hours. This short-acting pulsatile effect makes it suitable for once-daily administration to support physiological GH patterns. Animal studies have shown that even chronic daily exposure did not significantly desensitize GH release mechanisms, though cycling is recommended as a precautionary measure. Ipamorelin has also demonstrated pro-motility effects in the gastrointestinal tract via GHSR-1a receptors, with preclinical and clinical studies showing it can accelerate gastric emptying.
Potential Benefits & Side Effects
Observations from preclinical and clinical literature.
- Supports increases in lean body mass and improvements in recovery through GH-mediated anabolic processes.
- Enhances fat metabolism and supports favorable body composition changes over time.
- High selectivity for GH release with minimal impact on other hormones (ACTH, cortisol, prolactin).
- May support improved gastric motility and digestive function.
- Generally well tolerated with a low incidence of side effects at typical doses.
- Occasional mild injection-site reactions (redness, swelling) may occur; very rare reports of water retention or increased hunger.
Lifestyle Factors
Complementary strategies for best outcomes.
- Pair with a balanced, protein-adequate diet to support muscle synthesis and recovery.
- Combine resistance training and cardiovascular exercise to maximize anabolic and metabolic benefits.
- Prioritize 7–9 hours of quality sleep nightly, as GH naturally peaks during deep sleep phases.
- Manage stress levels, as chronic stress and elevated cortisol can blunt GH response.
- Inject on an empty stomach (avoid food 2–3 hours before and 30–60 minutes after) to optimize GH release.
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
- Clean your hands and work on a clean surface.
- Swab the vial’s rubber stopper and injection site with alcohol; allow to dry.
- Draw the calculated dose into the insulin syringe, eliminating air bubbles.
- Suitable SC injection areas include the abdomen (2 inches from navel), outer thighs, upper outer arms, or flank/hip area.
- Pinch a fold of skin between thumb and forefinger; insert the needle at 45–90° into subcutaneous tissue.
- Do not aspirate for subcutaneous injections; inject slowly and steadily.
- After injection, release the pinched skin and withdraw the needle at the same angle.
- Apply gentle pressure with a clean cotton or alcohol pad; do not rub vigorously.
- Rotate sites systematically with each dose to prevent irritation or tissue damage.
- Immediately dispose of the used syringe in a proper sharps container.
Recommended Source
Why Amino Labs?
- Third-party tested: Each batch includes Certificate of Analysis (COA) verifying purity and composition.
- Consistent quality: ISO-aligned manufacturing and handling standards ensure reliable product integrity.
- Cold-chain integrity: Temperature-controlled shipping and storage throughout fulfillment process.
- Research-grade purity: Suitable for educational and research applications requiring high-quality peptides.
Note: Product availability and specifications subject to change. Verify current product details on supplier website.
Shop at Amino Labs
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.